[Pharmacodynamic studies after short- and long-term treatment with radioactively labelled 3-(beta-diethylamino-ethyl)-4-methyl-7-carbethoxy-2-oxo-(1,2-chromene)-hydrochloride in animal experiments].
D000284:Administration, Oral; D000818:Animals; D002247:Carbon Isotopes; D003374:Coumarins / Q000008:administration & dosage / Q000378:metabolism* / Q000652:urine; D005243:Feces / Q000032:analysis; D005260:Female; D005333:Fetus / Q000378:metabolism; D006016:Glycolates / Q000008:administration & dosage / Q000378:metabolism* / Q000652:urine; D006207:Half-Life; D007274:Injections, Intraperitoneal; D007408:Intestinal Absorption; D008297:Male; D051379:Mice; D009206:Myocardium / Q000378:metabolism; D011247:Pregnancy; D011270:Pregnancy, Animal; D051381:Rats; D013997:Time Factors; D014915:Whole-Body Counting
D002247:Carbon Isotopes; D003374:Coumarins; D006016:Glycolates
Pharmakodynamische Untersuchungen nach Kurz- und Langzeit-Behandlung mit radioaktiv markiertem 3-(beta-Diäthylamino-äthyl)-4-methyl-7-carbäthoxy-methoxy-2-oxo-(1,2-chromen)-hydrochlorid im Tierexperiment.